Home › Migraine › New York › New York City
Migraine clinical trials in New York City, NY
6 studies for Migraine are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
MMA Embolization for Refractory Chronic Migraine
Recruiting
- Mount Sinai, New York
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
RecruitingPhase 3
- New York Neurology Associates, New York
- Weill Cornell Medicine, New York
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
RecruitingPhase 3
- New York Neurology Associates, New York
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
RecruitingPhase 4
- Mt Sinai Icahn School of Medicine, New York
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
RecruitingPhase 3
- Fieve Clinical Research, Inc, New York
RELAXaHEAD for Headache Patients (Phase III)
Recruiting
- NYU Langone Health, New York
About Migraine
Migraines are pulsing or throbbing headaches in one area of the head. Learn about other symptoms, what triggers migraines, and how to treat them.
More about Migraine on MedlinePlus
Migraine trials in other cities
- Cincinnati, OH11 studies
- Concord, CA8 studies
- Philadelphia, PA8 studies
- Austin, TX8 studies
- Miami, FL8 studies
- Amherst, NY7 studies
- Houston, TX7 studies
- Omaha, NE7 studies
- Washington, DC7 studies
- Aurora, CO6 studies
- San Diego, CA6 studies
- Atlanta, GA6 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.